ENDARI FDA approval date

The FDA approved ENDARI on 7 Jul 2017.

FDA approval date
7 Jul 2017

Drug identity has not yet been verified against registry records

Also recorded as L-GLUTAMINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-07-07DayENDARIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208587", "applicant_as_listed_by_fda": "EMMAUS MEDCL", "brand_names": ["ENDARI"], "active_ingredients": ["L-GLUTAMINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170707", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026